HRS-1893 - Jiangsu Hengrui Pharma
A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Aug 21, 2025 - P3 | N=216 | Recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting 
Enrollment open • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy
http://clinicaltrials.gov/ct2/show/NCT07021976
 
Aug 21, 2025
 
Prev Next